{
    "organizations": [],
    "uuid": "b97362c6b40d63b3a05ac788dff3d2384f5f261d",
    "author": "Reuters Editorial",
    "url": "https://www.reuters.com/article/brief-sangui-biotech-international-q3-op/brief-sangui-biotech-international-q3-oper-loss-reduced-idUSFWN1SB0F0",
    "ord_in_thread": 0,
    "title": "BRIEF-Sangui Biotech International Q3 Oper Loss Reduced",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "May 4 (Reuters) - Sangui Biotech International Inc:\n* OPERATING LOSS FOR Q3 OF 2018 DECREASED BY USD 6,856 YEAR-ON-YEAR TO USD 68,798.\n* 9MTH REVENUES FROM ROYALTY INCOME AND PRODUCT SALES OF USD 65,273 VERSUS USD 47,186 YE AGO Source text for Eikon: Further company coverage: (Gdynia Newsroom)\n ",
    "published": "2018-05-04T16:01:00.000+03:00",
    "crawled": "2018-05-05T12:22:43.040+03:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "may",
        "reuters",
        "sangui",
        "biotech",
        "international",
        "inc",
        "operating",
        "loss",
        "q3",
        "decreased",
        "usd",
        "usd",
        "9mth",
        "revenue",
        "royalty",
        "income",
        "product",
        "sale",
        "usd",
        "versus",
        "usd",
        "ye",
        "ago",
        "source",
        "text",
        "eikon",
        "company",
        "coverage",
        "gdynia",
        "newsroom"
    ]
}